A Phase 4 interventional study of buprenorphine and morphine in Cesarean Delivery, sponsored by Icahn School of Medicine at Mount Sinai. Recruiting at 1 site in United States. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.
Sponsored by Icahn School of Medicine at Mount Sinai · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.
Icahn School of Medicine at Mount Sinai is the lead sponsor of 776 studies on the registry; 175 are open to participants now.
Of its 125 completed or terminated interventional studies of FDA-regulated products, 83 (66%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Presenting for singleton elective cesarean delivery at term gestation.
Exclusion Criteria:
Patients receive 60 mcg buprenorphine as a part of their spinal medications.
Drug: buprenorphine
Patients receive 125 mcg morphine as a part of their spinal medications
Drug: morphine
60 mcg buprenorphine intrathecal
125mcg morphine intrathecal
Morphine equivalents administered within 24 hours after spinal administration
The total sum of opiates will be converted into morphine equivalents and compared between the groups for the first 24 hours after the spinal is administered.
Time frame: 24 hours
Morphine Equivalents at 48 Hours
The total sum of opiates will be converted into morphine equivalents and compared between the groups for the first 48 hours after the spinal is administered.
Time frame: 48 hours
Morphine Equivalents at 72 Hours
The total sum of opiates will be converted into morphine equivalents and compared between the groups for the first 72 hours after the spinal is administered.
Time frame: 72 hours
Obstetric Quality of Recovery-10 (ObsQoR-10) Score
Recovery score of the OBSQOR10 instrument at 24 hours, 48 hours, and 72 hours post spinal. Obstetric Quality of Recovery-10 (ObsQoR-10) is a 10-item instrument. Full scale is scored from 0-100 with higher score indicating better health outcomes.
Time frame: 24 hours, 48 hours, and 72 hours post spinal administration
Pruritus Scores PACU
Pruritus scores full scale scored from 1-5 with higher score indicating more pruritus.
Time frame: during PACU stay, about 6 hours
Pruritus Scores POD1-3
Pruritus scores full scale scored from 1-5 with higher score indicating more pruritus at 24 hour intervals for 3 days after spinal.
Time frame: at 24 hours intervals for 72 hours
Floor Pain Scores over 24 hours
Pain scores obtain by nursing team over the first 24 hours while on regular hospital floor. Pain scored from 0-10, with higher score indicating more pain.
Time frame: through 24 hours
Plan to share: No — The researchers may want to do a follow up study and reuse some of the data
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Aug 2028, 22 months after the start.
Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Oct 16, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Buprenorphine
Icahn School of Medicine at Mount Sinai →